Fibrosis: all 1,270 studies

Page 4 of 13. Open to participants first (276), then studies with results posted, then the rest; newest registration first within each.

• Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025CompletedNCT03907540Phase 1Results posted
• FMT in Cirrhosis and Hepatic EncephalopathyCompletedNCT03796598Phase 1/2Results posted
• Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring PreventionCompletedNCT03795116Phase 2Results posted
• Low-Level Laser in Treatment of Head and Neck Lymphedema: A Pilot StudyCompletedNCT03738332Not applicableResults posted
• Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic ImpairmentTerminatedNCT03633227Phase 4Results posted
• Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer SurvivorsActive, not recruitingNCT03612531Not applicableResults posted
• Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda InterferonCompletedNCT03600714Phase 2Results posted
• Health IT Generated PROs to Improve Outcomes in CirrhosisCompletedNCT03564626Not applicableResults posted
• Mild Hypothermia and Acute Kidney Injury in Liver TransplantationTerminatedNCT03534141Not applicableResults posted
• Safety, Tolerability and Pharmacodynamics of SYNB1020TerminatedNCT03447730Phase 1/2Results posted
• Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14CompletedNCT03439189Results posted
• Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?CompletedNCT03368066Phase 3Results posted
• Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03235349Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 InfectionCompletedNCT03219216Phase 3Results posted
• Ropinirole for the Treatment of Muscle Cramps in Patients With CirrhosisCompletedNCT03176966Phase 4Results posted
• Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) StudyCompletedNCT03154476Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary FibrosisTerminatedNCT03142191Phase 2Results posted
• Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory AscitesCompletedNCT03107091Phase 2Results posted
• Ramelteon for Treatment of Insomnia in CirrhosisCompletedNCT03091738Phase 4Results posted
• A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated CirrhosisCompletedNCT03089944Phase 3Results posted
• A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT03067129Phase 2/3Results posted
• Yttrium-90 Radioembolization for Cirrhosis-Associated ThrombocytopeniaTerminatedNCT03059030Not applicableResults posted
• Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian FederationCompletedNCT03053180Results posted
• Self-Care for Head and Neck Cancer Survivors With Lymphedema and FibrosisCompletedNCT03030859Not applicableResults posted
• Palliative Care for Non-Malignant Diseases (COMPASS Trial)TerminatedNCT03022630Not applicableResults posted
• Phase 2b Study in NASH to Assess IVA337CompletedNCT03008070Phase 2Results posted
• Simvastatin in Preventing Liver Cancer in Patients With Liver CirrhosisCompletedNCT02968810Phase 2Results posted
• Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal HypertensionCompletedNCT02960204Phase 2Results posted
• Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™CompletedNCT02958345Phase 4Results posted
• Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)CompletedNCT02854631Phase 2Results posted
• Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)CompletedNCT02854605Phase 2Results posted
• Shear Wave Elastography in Native Kidney DiseaseTerminatedNCT02830438Not applicableResults posted
• A Physical Activity Program in End-state Liver DiseaseCompletedNCT02776553Not applicableResults posted
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)TerminatedNCT02704403Phase 3Results posted
• A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary FibrosisCompletedNCT02688647Phase 2Results posted
• Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral TreatmentCompletedNCT02648022Not applicableResults posted
• Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis CCompletedNCT02640547Results posted
• Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in HungaryCompletedNCT02636608Results posted
• Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)CompletedNCT02615145Results posted
• Patient Buddy App for the Prevention of Avoidable Readmission in CirrhosisCompletedNCT02534805Results posted
• Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver TransplantCompletedNCT02533934Phase 4Results posted
• Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary FibrosisCompletedNCT02503657Phase 2Results posted
• FibroTouch Non-invasive Evaluation of Liver Fibrosis and CirrhosisCompletedNCT02476695Results posted
• Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3CompletedNCT02466516Phase 2Results posted
• Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and CoagulopathyCompletedNCT02457403Not applicableResults posted
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus InfectionCompletedNCT02442284Phase 3Results posted
• Shear Wave Sonoelastography in Pediatric Liver FibrosisCompletedNCT02372682Results posted
• Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 InfectionCompletedNCT02349048Phase 2Results posted
• Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV InfectionCompletedNCT02346721Phase 3Results posted
• Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary CholangitisTerminatedNCT02308111Phase 4Results posted
• Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 CirrhoticsCompletedNCT02304159Phase 4Results posted
• Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot StudyCompletedNCT02298868Phase 2Results posted
• A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C InfectionTerminatedNCT02292706Results posted
• A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASHCompletedNCT02279524Phase 2Results posted
• Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the LiverCompletedNCT02273362Phase 1/2Results posted
• Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in EgyptCompletedNCT02247401Phase 3Results posted
• Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated CirrhosisCompletedNCT02224456Phase 4Results posted
• Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV InfectionCompletedNCT02220998Phase 3Results posted
• A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT02219490Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated CirrhosisCompletedNCT02219477Phase 3Results posted
• Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney DiseaseCompletedNCT02207088Phase 3Results posted
• Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV InfectionCompletedNCT02201953Phase 3Results posted
• Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV InfectionCompletedNCT02201940Phase 3Results posted
• Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B CirrhosisCompletedNCT02201901Phase 3Results posted
• The SIM-SOF Trial for Hepatitis CCompletedNCT02168361Phase 4Results posted
• A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT02167945Phase 3Results posted
• Treatment of Type I Hepatorenal Syndrome (HRS) With PentoxyfyllineTerminatedNCT02123576Not applicableResults posted
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without CirrhosisCompletedNCT02114177Phase 3Results posted
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and CirrhosisCompletedNCT02114151Phase 3Results posted
• Ultrasound Method to Measure Fibrosis of the Liver in ChildrenTerminatedNCT02086708Not applicableResults posted
• Evaluation of the Strip PeriScreen for the Fast Diagnosis of the Spontaneous Infection of the Liquid of Ascites During the CirrhosisCompletedNCT02085915Not applicableResults posted
• Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV TrialCompletedNCT02049307Phase 2Results posted
• A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)CompletedNCT01995071Phase 2Results posted
• A Phase 2 Study of RO7490677 In Participants With MyelofibrosisCompletedNCT01981850Phase 2Results posted
• Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary FibrosisCompletedNCT01969409Phase 2Results posted
• Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)CompletedNCT01966419Phase 2Results posted
• Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV InfectionCompletedNCT01965535Phase 2Results posted
• The Association With Peptic Ulcer Disease and Hepatic Vein Pressure GradientCompletedNCT01944878Results posted
• Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLFTerminatedNCT01937130Phase 2Results posted
• New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis CCompletedNCT01888900Phase 2Results posted
• Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIVCompletedNCT01852942Phase 2Results posted
• Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic EncephalopathyTerminatedNCT01846663Phase 4Results posted
• The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic EncephalopathyCompletedNCT01842581Phase 4Results posted
• Pentoxifylline Therapy in Biliary AtresiaTerminatedNCT01774487Phase 2Results posted
• Study of Topical Superoxide Dismutase to Treat Radiation Induced FibrosisCompletedNCT01771991Not applicableResults posted
• Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT01769196Phase 2Results posted
• Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT01759511Phase 2Results posted
• Sonoelastography: Ultrasound Method to Measure Liver FibrosisCompletedNCT01747772Not applicableResults posted
• Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver FibrosisCompletedNCT01707472Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated CirrhosisCompletedNCT01704755Phase 3Results posted
• Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)CompletedNCT01694849Phase 2Results posted
• Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver DecompensationCompletedNCT01687257Phase 2Results posted
• Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASHTerminatedNCT01672879Phase 2Results posted
• An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal HypertensionCompletedNCT01640964Phase 2Results posted
• HRQoL in the Low MELD Pre-tx PopulationCompletedNCT01573325Results posted
• Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary CirrhosisCompletedNCT01473524Phase 3Results posted
• Proton Pump Inhibitors and Dysbiosis in CirrhosisCompletedNCT01458990Not applicableResults posted
• Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk PatientsCompletedNCT01446666Results posted
• Improving Performance of Paracentesis in Medical Residency TrainingCompletedNCT01403987Not applicableResults posted
• Tolvaptan for Ascites in Cirrhotic PatientsCompletedNCT01292304Phase 4Results posted

← Fibrosis overview